Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis
- PMID: 15929165
- PMCID: PMC4316046
- DOI: 10.3748/wjg.v11.i21.3182
Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis
Abstract
Aim: To evaluate the role of CDX2 homeobox protein as a predictor for cancer progression and prognosis as well as its correlation with MUC2 expression. CDX2 represents a transcription factor for various intestinal genes (including MUC2) and thus an important regulator of intestinal differentiation, which could previously be identified in gastric carcinomas and intestinal metaplasia.
Methods: Formalin-fixed and paraffin-embedded tissues from 190 gastric carcinoma patients were stained with monoclonal antibodies recognizing CDX2 and MUC2, respectively. Immunoreactivity was evaluated semiquantitatively and statistical analyses including chi(2) tests, uni- and multi-variate survival analyses were performed.
Results: CDX2 was mostly expressed in a nuclear or supranuclear pattern, whereas MUC2 showed an almost exclusive supranuclear reactivity. Both antigens were present in >80% of areas exhibiting intestinal metaplasia. An immunoreactivity in >5% of the tumor area was observed in 57% (CDX2) or in 21% (MUC2) of the carcinomas. The presence of both molecules did not correlate with WHO, Lauren and Goseki classification (with the exception of a significantly stronger MUC2 expression in mucinous tumors). CDX2 correlated with a lower pT and pN stage in the subgroups of intestinal and stage I cancers and was associated with MUC2 positivity. A prognostic impact of CDX2 or MUC2 was not observed.
Conclusion: CDX2 and MUC2 play an important role in the differentiation of normal, inflamed, and neoplastic gastric tissues. According to our results, loss of CDX2 may represent a marker of tumor progression in early gastric cancer and carcinomas with an intestinal phenotype.
Figures
Similar articles
-
Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.J Pathol. 2003 Jan;199(1):36-40. doi: 10.1002/path.1246. J Pathol. 2003. PMID: 12474224
-
Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.Int J Cancer. 1998 Apr 17;79(2):133-8. doi: 10.1002/(sici)1097-0215(19980417)79:2<133::aid-ijc6>3.0.co;2-u. Int J Cancer. 1998. PMID: 9583726
-
The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.J Cancer Res Clin Oncol. 2011 Dec;137(12):1749-62. doi: 10.1007/s00432-011-1044-7. Epub 2011 Sep 10. J Cancer Res Clin Oncol. 2011. PMID: 21909647 Free PMC article.
-
Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188579. doi: 10.1016/j.bbcan.2021.188579. Epub 2021 Jun 15. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34139275 Review.
-
CDX-2, a new marker for adenocarcinoma of gastrointestinal origin.Adv Anat Pathol. 2004 Mar;11(2):101-5. doi: 10.1097/00125480-200403000-00004. Adv Anat Pathol. 2004. PMID: 15090846 Review.
Cited by
-
From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases.Cell Commun Signal. 2017 Apr 20;15(1):15. doi: 10.1186/s12964-017-0171-4. Cell Commun Signal. 2017. PMID: 28427431 Free PMC article. Review.
-
Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.J Exp Clin Cancer Res. 2012 Nov 26;31(1):98. doi: 10.1186/1756-9966-31-98. J Exp Clin Cancer Res. 2012. PMID: 23181722 Free PMC article.
-
CDX-1/CDX-2 Expression Is a Favorable Prognostic Factor in Epstein-Barr Virus-Negative, Mismatch Repair-Proficient Advanced Gastric Cancers.Gut Liver. 2021 Sep 15;15(5):694-704. doi: 10.5009/gnl20203. Gut Liver. 2021. PMID: 34312322 Free PMC article.
-
Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.PLoS One. 2014 Jan 29;9(1):e86853. doi: 10.1371/journal.pone.0086853. eCollection 2014. PLoS One. 2014. PMID: 24489794 Free PMC article.
-
Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches.Biomedicines. 2025 Apr 15;13(4):964. doi: 10.3390/biomedicines13040964. Biomedicines. 2025. PMID: 40299656 Free PMC article. Review.
References
-
- Macdonald PM, Struhl G. A molecular gradient in early Drosophila embryos and its role in specifying the body pattern. Nature. 1986;324:537–545. - PubMed
-
- Drummond F, Putt W, Fox M, Edwards YH. Cloning and chromosome assignment of the human CDX2 gene. Ann Hum Genet. 1997;61:393–400. - PubMed
-
- Gehring WJ, Müller M, Affolter M, Percival-Smith A, Billeter M, Qian YQ, Otting G, Wüthrich K. The structure of the homeodomain and its functional implications. Trends Genet. 1990;6:323–329. - PubMed
-
- Cillo C. HOX genes in human cancers. Invasion Metastasis. 1994;14:38–49. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous